{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T04:47:50Z","timestamp":1777351670801,"version":"3.51.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T00:00:00Z","timestamp":1634774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T00:00:00Z","timestamp":1634774400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Suzhou Special Technical Project for Diagnosis and Treatment of Key Clinical Diseases","award":["No. LCZX201931"],"award-info":[{"award-number":["No. LCZX201931"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Patients hospitalized with chronic obstructive pulmonary disease (COPD) exacerbations are unable to complete the pulmonary function test reliably due to their poor health conditions. Creating an easy-to-use instrument to identify the Global Initiative for Chronic Obstructive Lung Disease (GOLD) stage will offer valuable information that assists clinicians to choose appropriate clinical care to decrease the mortality in these patients. The objective of this study was to develop a prediction model to identify the GOLD stage in the hospitalized exacerbation of chronic obstructive pulmonary disease (ECOPD) patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This prospective study involved 155 patients hospitalized for ECOPD. All participants completed lung function tests and the collection of blood neutrophils and demographic parameters. Receiver operating characteristic (ROC) curve was plotted based on the data of 155 patients, and was used to analyze the disease severity predictive capability of blood neutrophils and demographic parameters. A support vector regression (SVR) based GOLD stage prediction model was built using the training data set (75%), whose accuracy was then verified by the testing data set (25%).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The percentage of blood neutrophils (denoted as NEU%) combined with the demographic parameters was associated with a higher risk to severe episode of ECOPD. The area under the ROC curve was 0.84. The SVR model managed to predict the GOLD stage with an accuracy of 90.24%. The root-mean-square error (RMSE) of the forced expiratory volume in one second as the percentage of the predicted value (denoted as FEV<jats:sub>1<\/jats:sub>%pred) was 8.84%.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The NEU% and demographic parameters are associated with the pulmonary function of the hospitalized ECOPD patients. The established prediction model could assist clinicians in diagnosing GOLD stage and planning appropriate clinical care.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12890-021-01696-z","type":"journal-article","created":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T21:02:48Z","timestamp":1634850168000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Prediction of gold stage in patients hospitalized with COPD exacerbations using blood neutrophils and demographic parameters as risk factors"],"prefix":"10.1186","volume":"21","author":[{"given":"Jing","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qun","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-quan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Da-xi","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,21]]},"reference":[{"key":"1696_CR1","unstructured":"GOLD. Global strategy for the diagnosis, management and prevention of COPD, global initiative for chronic obstructive lung disease (GOLD);2019. [Update 2019] Available from: http:\/\/goldcopd.org. Accessed 5 Feb 2019"},{"key":"1696_CR2","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.05-020415","volume":"5","author":"D Adeloye","year":"2015","unstructured":"Adeloye D, Chua S, Lee C, Basquill C, Papana A, Theodoratou E, et al. Global and regional estimates of COPD prevalence: systematic review and meta-analysis. J Glob Health. 2015;5: 020415. https:\/\/doi.org\/10.7189\/jogh.05-020415.","journal-title":"J Glob Health"},{"key":"1696_CR3","unstructured":"Projections of mortality and causes of death, 2015 and 2030. Geneva: World Health Organization; Available from: http:\/\/www.who.int\/healthinfo\/global_burden_disease\/projections\/en\/. Accessed on 11 Sept 2017."},{"key":"1696_CR4","doi-asserted-by":"publisher","first-page":"46s","DOI":"10.1183\/09031936.03.00078002","volume":"41","author":"S Burge","year":"2003","unstructured":"Burge S, Wedzicha JA. COPD exacerbations: definitions and classifications. Eur Respir J Suppl. 2003;41:46s\u201353s.","journal-title":"Eur Respir J Suppl"},{"key":"1696_CR5","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/5584_2015_178","volume":"884","author":"R Rubinsztajn","year":"2016","unstructured":"Rubinsztajn R, Przybylowski T, Maskey-Warzechowska M, Karwat K, Chazan R. Exacerbations of chronic obstructive pulmonary disease and quality of life of patients. Adv Exp Med Biol. 2016;884:69\u201374.","journal-title":"Adv Exp Med Biol"},{"key":"1696_CR6","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1136\/thorax.57.10.847","volume":"57","author":"GC Donaldson","year":"2002","unstructured":"Donaldson GC, Seemungal TAR, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002;57:847\u201352.","journal-title":"Thorax"},{"key":"1696_CR7","doi-asserted-by":"crossref","unstructured":"Schmidt SAJ, Johansen MB, Olsen M, Xu X, Parker JM, Molfino NA, Lash TL, S\u00f8rensen HT, Christiansen CF. The impact of exacerbation frequency on mortality following acute exacerbations of COPD: a registry-based cohort study.\u00a0BMJ Open.\u00a02014;4:e006720.","DOI":"10.1136\/bmjopen-2014-006720"},{"issue":"2","key":"1696_CR8","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3904\/kjim.2020.035","volume":"35","author":"CK Rhee","year":"2020","unstructured":"Rhee CK, Kim DK. Role of phosphodiesterase-4 inhibitors in chronic obstructive pulmonary disease. Korean J Intern Med. 2020;35(2):276\u201383.","journal-title":"Korean J Intern Med"},{"issue":"2","key":"1696_CR9","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1183\/09031936.03.00405703","volume":"21","author":"AGN Agusti","year":"2003","unstructured":"Agusti AGN, Noguera A, Sauleda J, et al. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J. 2003;21(2):347\u201360.","journal-title":"Eur Respir J"},{"key":"1696_CR10","doi-asserted-by":"crossref","unstructured":"Jing Z , Chun C , Ning S , et al. Systemic inflammatory marker CRP was better predictor of readmission for AECOPD than sputum inflammatory markers. Arch Bronconeumol (English Edition), 2016.","DOI":"10.1016\/j.arbr.2015.05.029"},{"key":"1696_CR11","doi-asserted-by":"crossref","unstructured":"Gao J , Chen B , Wu S , et al. Blood cell for the differentiation of airway inflammatory phenotypes in COPD exacerbations. BMC Pulm Med, 2020, 20.","DOI":"10.1186\/s12890-020-1086-1"},{"key":"1696_CR12","doi-asserted-by":"crossref","unstructured":"Angela, M, Abbatecola, et al. Practical management problems of chronic obstructive pulmonary disease in the elderly: acute exacerbations. Curr Opin Pulm Med, 2011.","DOI":"10.1097\/01.mcp.0000410748.28582.22"},{"key":"1696_CR13","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3399\/bjgp17X690389","volume":"67","author":"A Fernandez-Villar","year":"2017","unstructured":"Fernandez-Villar A, Soriano JB, Lopez-Campos JL. Overdiagnosis of COPD: precise definitions and proposals for improvement. Br J Gen Pract. 2017;67:183\u20134.","journal-title":"Br J Gen Pract"},{"key":"1696_CR14","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1183\/13993003.01391-2014","volume":"47","author":"S Hartl","year":"2016","unstructured":"Hartl S, Lopez-Campos JL, Pozo-Rodriguez F, Castro-Acosta A, Studnicka M, Kaiser B, et al. Risk of death and readmission of hospital-admitted COPD exacerbations: European COPD Audit. Eur Respir J. 2016;47:113\u201321.","journal-title":"Eur Respir J"},{"key":"1696_CR15","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.chest.2017.01.003","volume":"151","author":"H Wu","year":"2017","unstructured":"Wu H, Wise RA, Medinger AE. Do patients hospitalized with COPD have airflow obstruction? Chest. 2017;151:1263\u201371.","journal-title":"Chest"},{"key":"1696_CR16","unstructured":"Ulmer WT. Lung function--clinical importance, problems, and new results. J PHYSIOL PHARMACOL, 2003, 54 Suppl 1(2):11."},{"key":"1696_CR17","unstructured":"Expert group on diagnosis and treatment of acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Chinese expert consensus on diagnosis and treatment of acute exacerbation of chronic obstructive pulmonary disease (AECOPD) (updated in 2017). Int J Respir, 2017, 37(14), 1041\u20131057."},{"key":"1696_CR18","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/978-1-4757-3264-1","volume-title":"The nature of statistical learning theory","author":"VN Vapnik","year":"2000","unstructured":"Vapnik VN. The nature of statistical learning theory. New York: Springer; 2000. p. 138\u201367."},{"key":"1696_CR19","unstructured":"GLI-2012 desktop software for individual calculations. http:\/\/www.ers-education.org\/guidelines\/global-lung-function-initiative\/spirometry-tools\/desktop-individual-calculator.aspx. Last Access 3 June 2018."},{"issue":"42","key":"1696_CR20","first-page":"43","volume":"7","author":"CF Donner","year":"1997","unstructured":"Donner CF, Carone M, Bertolotti G, et al. Methods of assessment of quality of life. Eur Respir Rev. 1997;7(42):43\u20135.","journal-title":"Eur Respir Rev"},{"issue":"11","key":"1696_CR21","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1136\/thorax.58.11.920","volume":"58","author":"A Manhire","year":"2003","unstructured":"Manhire A, Charig M, Clelland C, et al. Guidelines for radiologically guided lung biopsy. Thorax. 2003;58(11):920\u201336.","journal-title":"Thorax"},{"issue":"1","key":"1696_CR22","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1465-9921-13-44","volume":"13","author":"MVD Berge","year":"2012","unstructured":"Berge MVD, Hop WC, Molen TVD, et al. Prediction and course of symptoms and lung function around an exacerbation in chronic obstructive pulmonary disease. Respir Res. 2012;13(1):44.","journal-title":"Respir Res"},{"issue":"4","key":"1696_CR23","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1164\/rccm.200712-1869OC","volume":"178","author":"BR Celli","year":"2008","unstructured":"Celli BR, Thomas NE, Anderson JA, et al. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008;178(4):332\u20138.","journal-title":"Am J Respir Crit Care Med"},{"key":"1696_CR24","doi-asserted-by":"crossref","unstructured":"Torun E , Cakir E , \u00d6zg\u00fc\u00e7, Fatma, et al. The effect of obesity degree on childhood pulmonary function tests. Balkan Med J, 2014, 31(3):235\u20138.","DOI":"10.5152\/balkanmedj.2014.13101"},{"key":"1696_CR25","doi-asserted-by":"crossref","unstructured":"Jing C,Yang Z, Qun Y et al. Prediction models for pulmonary function during acute exacerbation of chronic obstructive pulmonary disease. Physiol Meas, 2020, 41, 125010.","DOI":"10.1088\/1361-6579\/abc792"},{"key":"1696_CR26","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12931-020-01436-7","volume":"21","author":"M Lonergan","year":"2020","unstructured":"Lonergan M, Dicker AJ, Crichton ML, et al. Blood neutrophil counts are associated with exacerbation frequency and mortality in COPD. Respir Res. 2020;21:166.","journal-title":"Respir Res"},{"issue":"2","key":"1696_CR27","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1159\/000332834","volume":"83","author":"J Milara","year":"2012","unstructured":"Milara J, Juan G, Peiro T, Serrano A, Cortijo J. Neutrophil activation in severe, early-onset COPD patients versus healthy non-smoker subjects in vitro: effects of antioxidant therapy. Respiration. 2012;83(2):147\u201358.","journal-title":"Respiration"},{"issue":"6","key":"1696_CR28","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s00408-016-9930-z","volume":"194","author":"AW Jones","year":"2016","unstructured":"Jones AW, Robinson R, Mohamed P, Davison G, Izzat HJ, Lewis KE. Impaired blood neutrophil function in the frequent Exacerbator of chronic obstructive pulmonary disease: a proof-of-concept study. Lung. 2016;194(6):881\u20137.","journal-title":"Lung"},{"issue":"1","key":"1696_CR29","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12931-014-0115-0","volume":"15","author":"J Corhay","year":"2014","unstructured":"Corhay J, Moermans C, Henket M, et al. Increased of exhaled breath condensate neutrophil chemotaxis in acute exacerbation of COPD. Respir Res. 2014;15(1):115.","journal-title":"Respir Res"},{"issue":"3","key":"1696_CR30","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1183\/09031936.00092506","volume":"29","author":"WR Perera","year":"2007","unstructured":"Perera WR, Hurst JR, Wilkinson TM, et al. Inflammatory changes, recovery and recurrence at COPD exacerbation. Eur Respir J. 2007;29(3):527\u201334.","journal-title":"Eur Respir J"},{"key":"1696_CR31","doi-asserted-by":"crossref","unstructured":"Crist\u00f3bal, Esteban, Inmaculada, et al. A decision tree to assess short-term mortality after an emergency department visit for an exacerbation of COPD: a cohort study. Respir Res, 2015.","DOI":"10.1186\/s12931-015-0313-4"},{"issue":"1","key":"1696_CR32","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12931-018-0803-2","volume":"19","author":"NS Godtfredsen","year":"2018","unstructured":"Godtfredsen NS, Jrgensen DV, Marsaa K, et al. Soluble urokinase plasminogen activator receptor predicts mortality in exacerbated COPD. Respir Res. 2018;19(1):97.","journal-title":"Respir Res"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-021-01696-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-021-01696-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-021-01696-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T08:04:36Z","timestamp":1634889876000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-021-01696-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,21]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1696"],"URL":"https:\/\/doi.org\/10.1186\/s12890-021-01696-z","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,21]]},"assertion":[{"value":"4 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the declaration of Helsinki. The study and the use of clinical data were approved by the Ethics Committee of the Affiliated Suzhou Science and Technology Town Hospital of Nanjing Medical University (IRB20180009). And all the participants gave their written informed consent before any study procedures began.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"329"}}